eEx665

Caenorhabditis elegans

[trf-1p::dsRed2 + unc-119(+)]

NS2937

Caenorhabditis elegans

CB6761

Caenorhabditis elegans

21ur-12495

Caenorhabditis elegans

Enriched in VC4 and VC5 based on single-cell RNA-seq studies.

linc-26

Caenorhabditis elegans

Enriched in VC4 and VC5 based on single-cell RNA-seq studies. Is affected by swsn-1 based on RNA-seq studies. Is affected by Tamoxifen based on RNA-seq studies.

TL8

Caenorhabditis elegans

TL9

Caenorhabditis elegans

trf-1

Caenorhabditis elegans

Predicted to enable signaling adaptor activity. Involved in defense response to Gram-negative bacterium and innate immune response. Predicted to be located in cytoplasm. Expressed in CEMDL; CEMDR; CEMVL; CEMVR; and tail. Human ortholog(s) of this gene implicated in brain disease and lung adenocarcinoma. Is an ortholog of human TRAF4 (TNF receptor associated factor 4).

linc-14

Caenorhabditis elegans

Enriched in Q cell; VA1; VC4; VC5; and head mesodermal cell based on RNA-seq and single-cell RNA-seq studies. Is affected by several genes including etr-1; rrf-3; and srbc-48 based on RNA-seq studies. Is affected by graphene oxide; paraquat; and silicon dioxide nanoparticle based on RNA-seq and microarray studies.

NC571

Caenorhabditis elegans